Profile data is unavailable for this security.
About the company
Otsuka Holdings Co Ltd is a Japan-based company mainly engaged in medical, nutraceutical, consumer and other business activities in Japan and overseas. The Company operates in four business segments. The Medical Business segment produces and sells therapeutic drugs and infusions. The Nutraceutical segment produces and sells functional beverages, quasi-drugs and nutritional supplements. The Consumer Products segment produces and sells mineral water, beverages and food products. The Others segment manufactures paper containers, manufactures synthetic resin molded products, stores products, provides storage space, and produces and sells chemicals and liquid crystal evaluation equipment, spectroscopic analysis equipment, and other products.
- Revenue in JPY (TTM)2.47tn
- Net income in JPY363.15bn
- Incorporated2008
- Employees35.34k
- LocationOtsuka Holdings Co LtdShinagawa Grand Central Tower2-16-4, KonanMINATO-KU 108-8241JapanJPN
- Phone+81 367171410
- Fax+81 367171409
- Websitehttps://www.otsuka.com/jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ono Pharmaceutical Co Ltd | 509.35bn | 62.40bn | 1.25tn | 4.29k | 18.95 | 1.41 | 12.63 | 2.46 | 132.76 | 132.76 | 1,084.01 | 1,786.88 | 0.4702 | 2.14 | 3.38 | 118,811,500.00 | 5.77 | 10.78 | 6.61 | 12.37 | 69.79 | 73.23 | 12.27 | 21.23 | 2.56 | 125.26 | 0.1283 | 36.33 | -3.14 | 10.73 | -60.89 | -3.47 | -18.66 | 12.20 |
| Sumitomo Pharma Co Ltd | 453.40bn | 110.09bn | 1.27tn | 3.83k | 11.49 | 4.38 | 9.62 | 2.79 | 277.11 | 277.11 | 1,141.22 | 727.28 | 0.5438 | 1.95 | 3.99 | 118,318,100.00 | 13.20 | -5.49 | 23.02 | -8.49 | 59.24 | 67.88 | 24.28 | -13.24 | 1.01 | 4.17 | 0.4726 | -- | 26.79 | -3.75 | 107.50 | -10.32 | -0.4856 | -- |
| Kyowa Kirin Co Ltd | 496.83bn | 67.04bn | 1.37tn | 5.67k | 20.33 | 1.53 | 14.69 | 2.75 | 128.07 | 128.07 | 949.13 | 1,706.50 | 0.4568 | 1.82 | 2.99 | -- | 6.16 | 6.40 | 7.33 | 7.37 | 74.25 | 74.99 | 13.49 | 14.37 | 2.35 | -- | -- | 46.19 | 0.2559 | 9.31 | 11.98 | 7.35 | 19.80 | 7.10 |
| Eisai Co Ltd | 808.19bn | 42.76bn | 1.46tn | 13.51k | 32.97 | 1.59 | 17.42 | 1.80 | 151.67 | 151.67 | 2,866.61 | 3,153.46 | 0.5537 | 0.7996 | 3.33 | 59,839,040.00 | 3.04 | 3.81 | 4.22 | 5.14 | 77.75 | 77.47 | 5.48 | 6.44 | 1.54 | -- | 0.2015 | 98.01 | 6.42 | 2.56 | 9.49 | -17.54 | -14.48 | 0.00 |
| Shionogi & Co Ltd | 465.35bn | 194.86bn | 3.09tn | 4.96k | 15.19 | 1.95 | 14.33 | 6.65 | 228.94 | 228.94 | 546.70 | 1,779.33 | 0.2869 | 0.8648 | 2.76 | 93,915,640.00 | 11.98 | 12.17 | 13.13 | 13.74 | 84.50 | 84.91 | 41.78 | 38.30 | 5.21 | -- | 0.0148 | 27.87 | 0.7325 | 5.62 | 5.19 | 6.88 | 34.66 | 12.30 |
| Astellas Pharma Inc | 2.06tn | 322.91bn | 4.39tn | 13.64k | 13.50 | 2.46 | 8.52 | 2.13 | 179.57 | 179.57 | 1,145.43 | 984.21 | 0.5841 | 1.27 | 2.90 | 151,038,200.00 | 9.15 | 3.05 | 14.11 | 4.45 | 81.00 | 81.15 | 15.67 | 5.42 | 0.839 | 41.32 | 0.2913 | 131.42 | 19.25 | 8.01 | 197.72 | -23.64 | -5.94 | 13.09 |
| Daiichi Sankyo Co Ltd | 2.05tn | 304.60bn | 5.59tn | 19.77k | 18.03 | 3.19 | 14.76 | 2.72 | 163.62 | 163.62 | 1,103.05 | 924.09 | 0.5649 | 0.8183 | 3.11 | 103,827,400.00 | 8.38 | 5.72 | 10.55 | 7.11 | 77.54 | 72.15 | 14.84 | 11.03 | 1.85 | -- | 0.1495 | 49.57 | 17.77 | 13.95 | 44.47 | 17.77 | 29.01 | 20.79 |
| Otsuka Holdings Co Ltd | 2.47tn | 363.15bn | 5.60tn | 35.34k | 15.05 | 1.80 | 11.61 | 2.27 | 685.26 | 685.26 | 4,657.43 | 5,743.73 | 0.6221 | 2.08 | 4.57 | 69,865,070.00 | 9.23 | 5.91 | 11.37 | 7.27 | 71.68 | 69.18 | 14.83 | 9.89 | 1.67 | -- | 0.0685 | 32.93 | 15.42 | 10.78 | 182.13 | 21.96 | 15.32 | 3.71 |
| Takeda Pharmaceutical Co Ltd | 4.46tn | 112.93bn | 8.84tn | 47.46k | 76.90 | 1.15 | 10.28 | 1.98 | 72.26 | 72.26 | 2,834.46 | 4,838.54 | 0.2926 | 1.17 | 6.17 | 94,080,250.00 | 0.7418 | 1.71 | 0.8772 | 2.04 | 65.33 | 67.66 | 2.54 | 5.99 | 0.6548 | 3.49 | 0.3884 | 123.75 | 7.45 | 6.84 | -25.08 | 19.53 | 9.82 | 1.72 |
| Chugai Pharmaceutical Co Ltd | 1.26tn | 434.01bn | 15.40tn | 7.78k | 34.77 | 7.45 | -- | 12.24 | 263.73 | 263.73 | 764.40 | 1,230.91 | 0.5379 | 1.41 | 3.59 | -- | 18.56 | 19.40 | 21.83 | 23.54 | 71.09 | 66.75 | 34.50 | 31.46 | 3.56 | 583.66 | -- | 40.95 | 7.46 | 9.84 | 12.06 | 15.11 | 12.69 | 17.27 |
Data as of Feb 18 2026. Currency figures normalised to Otsuka Holdings Co Ltd's reporting currency: Japanese Yen JPY
21.21%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 28 Nov 2025 | 26.18m | 4.82% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 15.94m | 2.94% |
| Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 15 Sep 2025 | 12.51m | 2.30% |
| Amova Asset Management Co., Ltd.as of 15 Sep 2025 | 12.25m | 2.26% |
| Daiwa Asset Management Co. Ltd.as of 30 Jan 2026 | 11.02m | 2.03% |
| Wellington Management Co. LLPas of 30 Jan 2026 | 10.43m | 1.92% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 9.71m | 1.79% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 05 Feb 2026 | 6.48m | 1.19% |
| Geode Capital Management LLCas of 12 Feb 2026 | 5.34m | 0.98% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 5.31m | 0.98% |
More ▼
Data from 30 Sep 2025 - 12 Feb 2026Source: FactSet Research Systems Inc.
